Budget Impact on the Use of Pegfilgrastim to Reduce the Febrile Neutropenia During Chemotherapy for Breast Cancer with Moderate Risk Compared to a Standard Therapy

Authors :: Yong Joo Lee
Sang Yhun Ju
C.M. Kim
S.B. Heo
W.S. Choi
Source :: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Publication Year :: 2016

Subjects :: Oncology
medicine.medical_specialty
Chemotherapy
business.industry
Health Policy
medicine.medical_treatment
Public Health, Environmental and Occupational Health
Budget impact
medicine.disease
Breast cancer
Internal medicine
medicine
Intensive care medicine
business
Standard therapy
Febrile neutropenia
Pegfilgrastim
medicine.drug

ISSN :: 15244733
Volume :: 17
Issue :: 7
Database :: OpenAIRE
Journal :: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Accession number :: edsair.doi.dedup.....41c220b1ed0b1f8bbdecf6ddcca9da1f

Tools